Department of Otolaryngology, Head and Neck Surgery, Xiangya Hospital, Central South University, Changsha 410008, Hunan, China; Department of Head and Neck Surgery, Hunan Provincial Tumor Hospital and the Affiliated Tumor Hospital of Xiangya School of Medicine, Central South University, Changsha 410013, Hunan, China; Province Key Laboratory of Otolaryngology Critical Diseases, Changsha 410008, Hunan, China.
Department of Otolaryngology, Head and Neck Surgery, Xiangya Hospital, Central South University, Changsha 410008, Hunan, China; Province Key Laboratory of Otolaryngology Critical Diseases, Changsha 410008, Hunan, China.
Gene. 2014 Mar 15;538(1):36-41. doi: 10.1016/j.gene.2014.01.026. Epub 2014 Jan 16.
Waardenburg syndrome type IV (WS4) is a rare genetic disorder, characterized by auditory-pigmentary abnormalities and Hirschsprung disease. Mutations of the EDNRB gene, EDN3 gene, or SOX10 gene are responsible for WS4. In the present study, we reported a case of a Chinese patient with clinical features of WS4. In addition, the three genes mentioned above were sequenced in order to identify whether mutations are responsible for the case. We revealed a novel nonsense mutation, c.1063C>T (p.Q355*), in the last coding exon of SOX10. The same mutation was not found in three unaffected family members or 100 unrelated controls. Then, the function and mechanism of the mutation were investigated in vitro. We found both wild-type (WT) and mutant SOX10 p.Q355* were detected at the expected size and their expression levels are equivalent. The mutant protein also localized in the nucleus and retained the DNA-binding activity as WT counterpart; however, it lost its transactivation capability on the MITF promoter and acted as a dominant-negative repressor impairing function of the WT SOX10.
瓦登伯格综合征 4 型(WS4)是一种罕见的遗传疾病,其特征为听觉-色素异常和先天性巨结肠。EDNRB 基因、EDN3 基因或 SOX10 基因突变可导致 WS4。本研究报道了一例中国患者,其临床表现符合 WS4。此外,我们对上述三个基因进行了测序,以确定突变是否与该病例相关。我们在 SOX10 的最后一个编码外显子中发现了一个新的无义突变 c.1063C>T(p.Q355*)。该突变未在 3 名无病家庭成员或 100 名无关对照中发现。然后,我们在体外研究了该突变的功能和机制。我们发现野生型(WT)和突变型 SOX10 p.Q355*均在预期大小处被检测到,且其表达水平相当。突变蛋白也定位于细胞核内,并保留与 WT 对应的 DNA 结合活性;然而,它失去了对 MITF 启动子的转录激活能力,作为显性负性抑制剂,损害 WT SOX10 的功能。